Nectar Lifesciences informs about disclosure

10 Jan 2025 Evaluate
Nectar Lifesciences has informed that the exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ingain Traders LLC, Vedanta Opportunities Fund LP, Isengard Direct PE LLC.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

23.60 0.06 (0.25%)
28-Mar-2025 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.70
Dr. Reddys Lab 1151.25
Cipla 1461.25
Lupin 2009.95
Zydus Lifesciences 899.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...